4/16
Coronavirus Research
Commonly used blood pressure meds may affect outcomes on COVID-19
Commonly used blood pressure meds may affect outcomes on COVID-19
Penn Medicine launches an international trial to study whether the medications are beneficial or harmful in the treatment of hospitalized patients.
Penn labs get creative to stay productive, connected
Penn labs get creative to stay productive, connected
In the face of a pandemic that has shuttered most physical laboratories across campus, researchers have shifted gears, maintaining work and social ties through grant- and manuscript-writing, virtual journal clubs, online coffee breaks, and more.
Measuring the risk among clinicians who intubate patients with COVID-19
Measuring the risk among clinicians who intubate patients with COVID-19
Penn launches a national component of global registry to track exposures and outcomes among providers who perform airway management procedures.
COVID-19 and lessons for public health
COVID-19 and lessons for public health
Six lessons for public health in the U.S. during the fight against COVID-19.
DIY origami face masks for COVID-19
DIY origami face masks for COVID-19
The professor of materials science and engineering and chemical and biomolecular engineering is leading an effort to design an effective face mask that can be made at home.
Is the U.S. winning the war against COVID-19?
Is the U.S. winning the war against COVID-19?
Ezekiel J. Emanuel, vice provost for global initiatives, gave a sobering update on how the United States is doing in the fight against COVID-19, saying the country needs to be prepared to battle the new coronavirus for about 18 months.
How can hospitals address scarce resources during COVID-19?
How can hospitals address scarce resources during COVID-19?
Most hospitals have general contingency plans for resource allocation in times of medical scarcity, but not detailed guidelines for the process of actually making those allocation decisions. School of Arts and Sciences political scientist and LDI Senior Fellow Julia Lynch has created those guidelines.
New trial will evaluate hydroxychloroquine to treat and prevent COVID-19
New trial will evaluate hydroxychloroquine to treat and prevent COVID-19
A new trial led by the Perelman School of Medicine will evaluate whether the drug hydroxychloroquine can benefit people infected with COVID-19 and whether taking the drug preventatively may help people avoid infection altogether.
Why clinical trials during disease outbreaks may need a new approach
Why clinical trials during disease outbreaks may need a new approach
Scientists around the world are racing to develop vaccines and treatments for the novel coronavirus, while hoping to avoid mistakes made during the West African Ebola epidemic, in which incomplete studies led to inconclusive results.
A quick pivot turns an infectious disease class into timely education
A quick pivot turns an infectious disease class into timely education
Students in David Roos’ upper-level biology course had been studying pandemics. Now they get to learn in real time how public health scientists attempt to understand COVID-19.
In the News
CBS News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Minnesota Public Radio
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Philadelphia Inquirer
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Boston Globe
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
NPR
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Time
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →